Cancers: Can We Beat the Odds? (Annual Meeting 2018)


President’s Address




About this Event

Cancers: Can We Beat the Odds?

NAM Member? Click here for more information.

The National Academy of Medicine will hold its annual meeting from Saturday through Monday, October 13-15, 2018, in Washington, DC at the National Academy of Sciences Building.


  • Saturday, October 13, 2017 (MEMBERS ONLY)
  • Sunday, October 14, 2017 (MEMBERS ONLY)
  • Monday, October 15, 2017 (8:00 am – 7:00 pm Eastern Time) 


Program Features: October 15, 2018

The full agenda can be found here.

Keynote: Cancer Immunotherapy: The End of the Beginning 

Laurie H. Glimcher, M.D., President and CEO, Dana-Farber Cancer Institute

Panel 1: Cancer Prevention: Promise and unrealized potential: half of all cancers could be prevented, why aren’t they?

ModeratorOtis W. Brawley, M.D., M.A.C.P., Chief Medical Officer, American Cancer Society; Professor of Hematology, Medical Oncology, Medicine, and Epidemiology, Emory University

New Strategies to Prevent Cancer: Obesity and Other Common Risk Factors: Cornelia Ulrich, M.S., Ph.D., Senior Director, Huntsman Cancer Institute

Inherited Cancer Genomics and Prevention: Kenneth Offit, M.D., M.P.H., Chief, Clinical Genetics Service, Department of Medicine; Member, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center

Targeting Cancer with Precision Prevention: Ernest Hawk, M.D., M.P.H., Vice President and Head, Division of Cancer Prevention and Population Sciences; T. Boone Pickens Distinguished Chair for Early Prevention of Cancer, The University of Texas MD Anderson Cancer Center

The Role of Vaccination in Cancer Prevention. Focus on HPV and Cervical Cancer- A Preventable Cancer That Is on the Rise Globally: Douglas R. Lowy, M.D., Deputy Director, National Cancer Institute, National Institutes of Health

Panel 2: The Biology of Cancers: Challenges for Therapeutics

Moderator: Levi A. Garraway, M.D., Ph.D., Senior Vice President, Oncology Research and Development, Eli Lilly and Company

Getting Ahead of Resistance: Kevan M. Shokat, Ph.D., Professor of Cellular and Molecular Pharmacology, Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Tumor Heterogeneity and Tumor Evolution: Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School

Overcoming Resistance to Molecularly Targeted Cancer Therapy: Charles Sawyers, M.D., Investigator, Howard Hughes Medical Institute; Marie-Jose and Harvey Kravis Chair in Human Oncology & Pathogenesis and Chairman, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center

Resistance to Immune Therapy: Antoni Ribas, M.D., Ph.D., Professor of  Surgery, Professor of Molecular and Medical Pharmacology, University of California, Los Angeles

Panel 3: Fighting Cancers:  From Biology to Policy

Moderator: Mary C. Beckerle, Ph.D., Jon M. Huntsman Presidential Endowed Chair, Chief Executive Officer, Huntsman Cancer Institute; Associate Vice President of Cancer Affairs, University of Utah

Cancer Genomics: Elaine R. Mardis, Ph.D., Nationwide Foundation Chair of Genomic Medicine, Co-Executive Director, Institute for Genomic Medicine, Nationwide Children’s Hospital

Precision CAR T Cell Therapeutics: Carl June, M.D., Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director, Center for Cellular Immunotherapies; Director, Parker Institute for Cancer Immunotherapy, University of Pennsylvania School of Medicine

Cancer Treatment and Financing: Commercial Payer Perspective: Lee Newcomer, M.D., M.H.A., Principal, Lee N. Newcomer Consulting, LLC

Cancer Drug Pricing and the Last Mile of Innovation: Peter B. Bach, M.D., MAPP, Director, Center for Health Policy and Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center


President’s Forum

Victor J. Dzau, president of the National Academy of Medicine, will host a forum on Affordable Medicines: Access, Innovation, and the Public Interest as part of the NAM’s Annual Meeting on Monday, October 15, from 4:05 to 5:45 pm in Washington, DC.

The forum will ​feature a special address by The Honorable Alex M Michael Azar II, JD, Secretary of the U.S. Department of Health and Human Services, and remarks by Senator Bill Cassidy (R-LA), Norman R. Augustine (Lockheed Martin Corporation; formerly), Gail K. Boudreaux (Anthem, Inc.), Kenneth C. Frazier (Merck & Co, Inc.), and John M. O’Brien (US Department of Health and Human Services).

The President’s Forum runs from 4:05 PM to 5:45 PM. The cost of registration is $15, and does not include breakfast, lunch, or the reception.



In addition to the scientific program, NAM President Dr. Victor J. Dzau will welcome the newest class of NAM members and will present the 2018 recipients of the Gustav O. Lienhard Award for Advancement of Health Care, the Rhoda and Bernard Sarnat International Prize in Mental Health, and the Member Awards.

Gustav O. Lienhard Award for Advancement of Health Care
Stuart Altman
2018 recipient

Rhoda and Bernard Sarnat International Prize in Mental Health
Kenneth Wells
2018 recipient


Follow along on Twitter using #NAMmtg and @theNAMedicine



For questions about the 2018 NAM Annual Meeting, contact Donna Duncan, Deputy Director of Council and Membership Services, at